FBLN2 and hepatocellular carcinoma: As shown in Figure 1B, higher expression of FBLN2 was observed in HCC tumor tissues (H-score: 266.76 ± 28.41) than the liver tissues present adjacent to the tumors (H-score: 227.37 ± 41.69) (P < .05).